XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities    
Net income $ 128,812,000 $ 641,207,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Provisions for credit losses 98,050,000 (225,767,000)
Income tax expense 37,356,000 203,525,000
Amortization of brokered deposit placement fee 3,425,000 4,307,000
Amortization of Secured Borrowing Facility upfront fee 569,000 773,000
Amortization of deferred loan origination costs and loan premium/(discounts), net 4,455,000 4,016,000
Net amortization of discount on investments 965,000 2,161,000
Reduction (increase) in tax indemnification receivable (108,000) 2,814,000
Depreciation of premises and equipment 4,189,000 3,715,000
Acquired intangible assets amortization expense 733,000 0
Stock-based compensation expense 11,921,000 11,124,000
Unrealized (gains) losses on derivatives and hedging activities, net 315,000 10,872,000
Gains on sales of loans, net (9,881,000) (399,111,000)
Acquisition transaction costs, net 2,511,000 0
Other adjustments to net income, net 7,235,000 2,578,000
Changes in operating assets and liabilities:    
Increase in accrued interest receivable (185,294,000) (183,168,000)
Increase in non-marketable securities (992,000) (317,000)
Decrease in other interest-earning assets 328,000 19,282,000
Increase in other assets (17,529,000) (51,667,000)
Decrease in income taxes payable, net (4,243,000) (270,000)
Increase (decrease) in accrued interest payable 14,779,000 (9,081,000)
Increase (decrease) in other liabilities (34,808,000) 8,759,000
Total adjustments (66,024,000) (595,455,000)
Total net cash provided by operating activities 62,788,000 45,752,000
Investing activities    
Loans acquired and originated (2,215,958,000) (2,076,635,000)
Net proceeds from sales of loans held for investment 45,729,000 3,436,391,000
Proceeds from FFELP Loan claim payments 5,594,000 4,602,000
Net decrease in loans held for investment (other than loan sales) 1,153,297,000 1,021,353,000
Purchases of available-for-sale securities (536,633,000) (200,716,000)
Proceeds from sales and maturities of available-for-sale securities 686,806,000 205,367,000
Purchase of subsidiary, net of cash acquired (127,702,000) 0
Total net cash (used in) provided by investing activities (988,867,000) 2,390,362,000
Financing activities    
Brokered deposit placement fee (2,207,000) 0
Net decrease in certificates of deposit (127,815,000) (686,344,000)
Net increase in other deposits 543,767,000 850,408,000
Borrowings collateralized by loans in securitization trusts - repaid (381,005,000) (272,123,000)
Issuance costs for unsecured debt offering (360,000) (325,000)
Fees paid on Secured Borrowing Facility 0 (2,833,000)
Common stock dividends paid (30,493,000) (10,906,000)
Preferred stock dividends paid (1,275,000) (1,201,000)
Common stock repurchased (169,322,000) (550,790,000)
Total net cash used in financing activities (168,710,000) (674,114,000)
Net increase (decrease) in cash, cash equivalents and restricted cash (1,094,789,000) 1,762,000,000
Cash, cash equivalents and restricted cash at beginning of period 4,545,344,000 4,609,709,000
Cash, cash equivalents and restricted cash at end of period 3,450,555,000 6,371,709,000
Cash disbursements made for:    
Interest 68,458,000 76,491,000
Income taxes paid 5,066,000 887,000
Income taxes refunded (916,000) (1,049,000)
Reconciliation of the Consolidated Statements of Cash Flows to the Consolidated Balance Sheets:    
Cash and cash equivalents 3,262,595,000 6,207,001,000
Restricted cash 187,960,000 164,708,000
Total cash, cash equivalents and restricted cash $ 3,450,555,000 $ 6,371,709,000